Intervention pilot trial for suppression of colibactin-producing E. coli implicated in colorectal carcinogenesis

ABSTRACT: Interventions: Colibactin positive patients are given biolactis (3 g/day) for 3 months. Primary outcome(s): Detection of colibactin-producing bacteria 90 days after the start of the intervention. Study Design: single arm study, open(masking not used), no treatment control/standard of care control, single assignment, basic science

DISEASE(S): Colorectal Neoplasia(endoscopically Removed),Colon Tumor

PROVIDER: 2615357 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR